1Heidenreich PA,Keeffe B, Mcdonald KM, et al. Overview of randomized trials of antiarrhythmic drugs and devices for the prevention of sudden cardiac death[J ]. Am Heart J, 2002,144: 422 - 430
3Bradv GH,Johnson G, Poole JE, et al. A simplified, single - lead unipolar transvenous cardioversion- defibrillation system [J ]. Circulation, 1993,88 : 543 - 547
4Estes M,Weinstock J,Wang PJ,et al. Use of antiarrhythmics and implantable cardioverter- defibrillators in congestive heart failure[J]. Am J Cardiol, 2003.91:45D- 52D
6Steinberg JS, Martins J, Sadanandan S, et al. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study [J]. Am Heart J, 2001, 142 : 520 - 529
7Irvine J, Cpsych D, Dorian P, et al. Quality of life in the Canadian Implantable Defibrillator Study(CIDS) [J]. Am Heart J,2002,144:282 - 289
二级参考文献32
1Marchlinski FE,Zado ES,Deely MP,et al.Concomitant device and drug therapy:current trends,potential benefits,and adverse interactions[J].Am J Cardiol,1999,84:69R
2Lauer MR,Young C,Liem LB,et al.Ventricular fibrillation induced by low-energy shocks from programmable implantable cardioverter-defibrillators in patients with coronary artery disease[J].Am J Cardiol,1994,73:559
3Brode SE,Schwartzman D,Callans DJ,et al.ICD-antiarrhythmic drug and ICD-pacemaker interactions[J].J Cardiovasc Electrophysiol,1997,8:830
5Steven SK,Haffajee CI,Naccarelli GV,et al.Effects of oral propafenone on defibrillation and pacing thresholds in patients receiving implantable cardioverter-defibrillators.Propafenone Defibrillation Threshold Investigators[J].J Am Coll Cardiol,1996,28:418
6Peters W,Gang ES,Okazaki H.Acute effects of intravenous propafenone on the internal ventricular defibrillation threshold in the anesthetized dog[J].Am Heart J,1991,122:1355
7Marchlinski FE,Flores B.Effects of procainamide on the defibrillation threshold in man(abtract)[J].Circulation,1988,78:II-154
8Dorian P,Fain ES,Davy JM.Lidocaine causes a reversible,concentration-dependent increase in defibrillation energy requirements[J].J Am Coll Cardiol,1986,8:327
9Marinchak RA,Friehling TD,Kline RA,et al.Effect of antiarrhythmic drugs on defibrillation threshold:Case report of an adverse effect of mexiletene and review of literature[J].PACE,1988,11:7
10Manz M,Jung W,Luderitz B.Interactions between drugs and devices:Experimental and clinical studies[J].Am Heart J,1994,127(Suppl):978
